Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12605000646640
Ethics application status
Approved
Date submitted
12/09/2005
Date registered
17/10/2005
Date last updated
27/04/2012
Type of registration
Retrospectively registered
Titles & IDs
Public title
A field study of the relationship between craving and self-efficacy in alcohol misuse
Query!
Scientific title
A Randomised Controlled Trial of Correspondence-Based Management of Alcohol Misuse within a Primary Care Setting
Query!
Secondary ID [1]
280409
0
Nil
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
DrinkRight
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Alcohol abuse and Alcohol dependence
777
0
Query!
Condition category
Condition code
Mental Health
852
852
0
0
Query!
Addiction
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
This project is associated with a similar correspondence-based treatment for alcohol misuse co-morbid with depression. It is a randomised controlled trial, in which participants are assigned to standard care by their GP or, standard care plus correspondence-based treatment. After three months, those in the standard care only group are provided the same treatment as the experimental group. The correspondence-based treatment is founded on empirically supported cognitive behaviour therapy for alcohol misuse and comprises four weekly and four fortnightly letters covering topics such as motivation enhancement, goal setting, dealing with urges, planning for high risk situations and relapse prevention.
Query!
Intervention code [1]
537
0
Treatment: Other
Query!
Comparator / control treatment
Standard care only
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
1094
0
The primary outcome being measured is the relationship between craving and self-efficacy. Craving is measured using The Desires for Alcohol Questionnaire (Clark et. al., 1996) and self-efficacy using the Controlled Drinking Self-Efficacy Scale (Sitharthan & Kavanagh, 1990) and Cognition Efficacy Questionnaire (Kavanagh & Wilson, 1989).
Query!
Assessment method [1]
1094
0
Query!
Timepoint [1]
1094
0
Measured prior to treatment, during treatment, immediately post-treatment and three, six, nine and 12 months after treatment.
Query!
Secondary outcome [1]
2030
0
the effectiveness of the correspondence-based treatment compared to standard care by a GP.
Query!
Assessment method [1]
2030
0
Query!
Timepoint [1]
2030
0
This is evaluated by measuring alcohol intake and craving levels prior to treatment, during treatment, immediately post-treatment and three, six, nine and 12 months after treatment.
Query!
Eligibility
Key inclusion criteria
An average intake over the past three months of >28 drinks per week for men or >14 drinks per week for women; meets DSM-IV criteria for an alcohol use disorder and sufficient oral and written English to participate without translation.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
Not stated
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
History of psychotic disorder; current misuse of other substances (except caffeine or nicotine); in concurrent treatment for alcohol at Baseline or residing at the same address as someone already enrolled in the study.
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocations will be placed in sealed envelopes by a person not connected with the trial.
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Random allocations to the two conditions will be done in blocks of four subjects using GraphPad Quickcalcs at GraphPad.com
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Date of first participant enrolment
Anticipated
1/01/2003
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
180
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
Query!
Funding & Sponsors
Funding source category [1]
939
0
Charities/Societies/Foundations
Query!
Name [1]
939
0
Alcohol Education and Rehabilitation Foundation Ltd
Query!
Address [1]
939
0
PO Box 3455
PARRAMATTA NSW 2124
Query!
Country [1]
939
0
Australia
Query!
Primary sponsor type
Individual
Query!
Name
Professor David J. Kavanagh
Query!
Address
IHBI, GPO Box 2434, Brisbane QLD 4001
Query!
Country
Australia
Query!
Secondary sponsor category [1]
797
0
Individual
Query!
Name [1]
797
0
Mr. Phillip Stacey
Query!
Address [1]
797
0
Unknown
Query!
Country [1]
797
0
Australia
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
2236
0
The University of Queensland Behavioural and Social Sciences Ethical Review Committee
Query!
Ethics committee address [1]
2236
0
Query!
Ethics committee country [1]
2236
0
Australia
Query!
Date submitted for ethics approval [1]
2236
0
Query!
Approval date [1]
2236
0
Query!
Ethics approval number [1]
2236
0
Query!
Summary
Brief summary
This project is associated with a similar correspondence-based treatment for alcohol misuse co-morbid with depression. It is a randomised controlled trial, in which participants are assigned to standard care by their GP or, standard care plus correspondence-based treatment. After three months, those in the standard care only group are provided the same treatment as the experimental group. The correspondence-based treatment is founded on empirically supported cognitive behaviour therapy for alcohol misuse and comprises four weekly and four fortnightly letters covering topics such as motivation enhancement, goal setting, dealing with urges, planning for high risk situations and relapse prevention.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
35264
0
Query!
Address
35264
0
Query!
Country
35264
0
Query!
Phone
35264
0
Query!
Fax
35264
0
Query!
Email
35264
0
Query!
Contact person for public queries
Name
9726
0
Professor David Kavanagh
Query!
Address
9726
0
IHBI, GPO Box 2434, Brisbane QLD 4001
Query!
Country
9726
0
Australia
Query!
Phone
9726
0
+61 7 31386143
Query!
Fax
9726
0
+61 7 31386030
Query!
Email
9726
0
[email protected]
Query!
Contact person for scientific queries
Name
654
0
Professor David Kavanagh
Query!
Address
654
0
IHBI, GPO Box 2434, Brisbane QLD 4001
Query!
Country
654
0
Australia
Query!
Phone
654
0
+61 7 31386143
Query!
Fax
654
0
+61 7 31386030
Query!
Email
654
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF